Brief Report
Issue Date: March/April 2021
Published Online: February 02, 2021
Updated: February 16, 2021
Initial Development and Evaluation of the Executive Function Performance Test–Enhanced (EFPT–E) in Women With Cancer-Related Cognitive Impairment
Author Affiliations
  • Anna E. Boone, PhD, MSOT, OTR/L, is Assistant Professor, Department of Occupational Therapy, University of Missouri–Columbia; booneae@health.missouri.edu
  • Timothy J. Wolf, PhD, OTD, OTR/L, FAOTA, is Associate Professor and Department Chair, Department of Occupational Therapy, University of Missouri–Columbia.
Article Information
Assessment Development and Testing / Education of OTs and OTAs / Mental Health / Rehabilitation, Participation, and Disability / Vision / Columns: Brief Report
Brief Report   |   February 02, 2021
Initial Development and Evaluation of the Executive Function Performance Test–Enhanced (EFPT–E) in Women With Cancer-Related Cognitive Impairment
American Journal of Occupational Therapy, February 2021, Vol. 75, 7502345020. https://doi.org/10.5014/ajot.2020.041210
American Journal of Occupational Therapy, February 2021, Vol. 75, 7502345020. https://doi.org/10.5014/ajot.2020.041210
Abstract

Importance: Psychometrically sound instruments are needed to evaluate executive functioning in the population of people with cancer.

Objective: To develop and evaluate the reliability and validity of the Executive Function Performance Test–Enhanced (EFPT–E) in women after being treated for breast cancer.

Design: Cross-sectional.

Setting: University research laboratory.

Participants: Women treated for breast cancer who had cognitive impairment (n = 12) and community control participants (n = 13).

Outcomes and Measures: Evaluators (n = 8) independently scored a recorded administration of the EFPT–E to evaluate interrater reliability. An assessment battery, including the EFPT–E, was administered to evaluate the EFPT–E’s known-groups validity and concurrent validity.

Results: Excellent interrater reliability was observed for the EFPT–E total score and each subtask score (intraclass correlation coefficient = .90–.98). Moderate effect sizes were noted for the EFPT–E total score (Cohen’s d = 0.5) and the total number of cues (d = 0.4) between the breast cancer group and the control group, with the breast cancer group demonstrating poorer performance. A limited correlation was found between the EFPT–E and the other cognitive measures.

Conclusions and Relevance: The results support the EFPT–E’s interrater reliability and warrant continued investigation to further establish its reliability and validity.

What This Article Adds: Assessments are needed to quantify the impact of cognitive processes within functional tasks. The EFPT–E has been developed to assess the functional impact of mild cognitive impairment; initial testing with women with cancer showed excellent agreement between raters and promising results for validity.